Amgen, Inc. (AMGN) Tops Q2 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Amgen (AMGN) PT Raised to $135 at BMO Capital
July 30, 2014 9:11 AM EDTBMO Capital analyst Jim Birchenough reiterated a Market Perform rating and bumped his price target on Amgen (NASDAQ: AMGN) to $135.00 (from $125.00) following Q2 results
Birchenough comments, "While AMGN continues to execute well on generating a return from legacy products, we believe that transformational growth... More
Amgen (AMGN) PT, Estimates Raised at Piper Jaffray Following 'Robust' Q2
July 30, 2014 9:07 AM EDTPiper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and boosted his price target on Amgen (NASDAQ: AMGN) to $150.00 (from $143.00) following "robust" Q2 results after the close.
Schimmer comments, "AMGN reported a robust 2Q after the close, with total revenue of $5.18B... More
